REE Automotive selected by Airbus UpNext
TEL AVIV, Israel, March 05, 2024 (GLOBE NEWSWIRE) — REE Automotive Ltd. (Nasdaq: REE) (“REE” or the “Company”) has been […]
Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis
Unique and memorable campaign intended to educate consumers about Demodex blepharitis and XDEMVY, the first and only FDA approved solution […]
SRAX SELECTS XDEFI AS WEB3 WALLET PARTNER, ENABLING SECURE ACCESS TO DIGITAL ASSETS FOR ACTIVE EQUITY INVESTORS
Los Angeles, March 05, 2024 (GLOBE NEWSWIRE) — Los Angeles, [5 March 2024] – SRAX Inc. (OTC: SRAX), a financial […]
Michael F. Roizen, MD to Increase Activities with Telomir Pharmaceuticals as Special Advisor on Age Reversal
Dr. Roizen to provide expertise on longevity and aging Research on aging involving Telomir’s lead product candidate focused on reversing age-related […]
Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update
SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the […]
KUSTOM ENTERTAINMENT ACQUIRES PRESTIGIOUS COUNTRY STAMPEDE MUSIC FESTIVAL
Growing entertainment company adds historic and impactful festival, as it gains momentum leading into 2024 festival season KANSAS CITY, March […]
NowVertical Signs Multi-Year Contract with Leading South African Bank in a $1.5 Million 3-Year Deal
TORONTO, March 05, 2024 (GLOBE NEWSWIRE) — NowVertical Group Inc. (“NowVertical” or the “Company”) (TSX-V: NOW) (OTCQB: NOWVF), a leading […]
Applied Digital Completes Financing for Jamestown HPC Data Center Campus
DALLAS, March 05, 2024 (GLOBE NEWSWIRE) — Applied Digital Corporation (Nasdaq: APLD) (“Applied Digital” or the “Company”), a designer, builder, […]
NextCure Publishes Preclinical Data Demonstrating Function of FLRT3 as a T Cell Inhibitor in Science Advances
BELTSVILLE, Md., March 05, 2024 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and […]
Catalyst Pharmaceuticals to Participate at the Barclays 26th Annual Global Healthcare Conference
CORAL GABLES, Fla., March 05, 2024 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage [...]
